PT Charlie Hospital Semarang Tbk (IDX:RSCH)
610.00
+15.00 (2.52%)
At close: Oct 9, 2026
IDX:RSCH Revenue
PT Charlie Hospital Semarang Tbk had revenue of 17.31B IDR in the quarter ending June 30, 2026, with 10.02% growth. This brings the company's revenue in the last twelve months to 119.46B, up 131.53% year-over-year. In the year 2025, PT Charlie Hospital Semarang Tbk had annual revenue of 114.40B with 135.86% growth. That makes PT Charlie Hospital Semarang Tbk the 38,948th largest company in the world by revenue and 720th in Indonesia.
Revenue (ttm)
119.46B
Revenue Growth
+131.53%
P/S Ratio
13.53
Revenue / Employee
558.23M
Employees
214
Market Cap
1.62T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 114.40B | 65.89B | 135.86% |
| Dec 31, 2024 | 48.50B | 6.34B | 15.04% |
| Dec 31, 2023 | 42.16B | 9.13B | 27.63% |
| Dec 31, 2022 | 33.03B | -2.52B | -7.10% |
| Dec 31, 2021 | 35.56B | 22.29B | 168.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 8.35T |
| PT Medikaloka Hermina Tbk | 7.35T |
| PT Famon Awal Bros Sedaya Tbk | 2.77T |
| PT Sarana Meditama Metropolitan Tbk | 1.98T |
| PT Bundamedik Tbk | 1.62T |
| PT Murni Sadar Tbk | 1.51T |
| PT Nitrasanata Dharma | 941.92B |
| PT Kedoya Adyaraya Tbk | 511.62B |